Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Atria | 10 | 2020 | 1361 | 1.620 |
Why?
|
| Atrial Flutter | 3 | 2019 | 253 | 1.570 |
Why?
|
| Catheter Ablation | 13 | 2020 | 2780 | 1.180 |
Why?
|
| Atrial Fibrillation | 15 | 2021 | 5176 | 0.960 |
Why?
|
| Galectin 3 | 1 | 2015 | 240 | 0.440 |
Why?
|
| Magnetic Resonance Imaging, Cine | 5 | 2019 | 1091 | 0.430 |
Why?
|
| Rib Fractures | 1 | 2013 | 124 | 0.400 |
Why?
|
| Atrial Function, Left | 3 | 2018 | 188 | 0.360 |
Why?
|
| Endocarditis | 1 | 2015 | 352 | 0.360 |
Why?
|
| Endocarditis, Bacterial | 1 | 2014 | 436 | 0.350 |
Why?
|
| Tricuspid Valve | 1 | 2013 | 419 | 0.350 |
Why?
|
| Troponin T | 1 | 2015 | 787 | 0.340 |
Why?
|
| Heart Rate | 2 | 2019 | 4214 | 0.340 |
Why?
|
| Mitral Valve | 1 | 2018 | 1475 | 0.330 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2013 | 362 | 0.320 |
Why?
|
| Defibrillators, Implantable | 2 | 2017 | 1498 | 0.320 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2018 | 1415 | 0.300 |
Why?
|
| Heart Conduction System | 4 | 2017 | 1009 | 0.300 |
Why?
|
| Pulmonary Veins | 4 | 2017 | 758 | 0.290 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 1566 | 0.280 |
Why?
|
| Adiponectin | 1 | 2013 | 1117 | 0.270 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 807 | 0.270 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3841 | 0.250 |
Why?
|
| Renal Dialysis | 1 | 2014 | 1791 | 0.240 |
Why?
|
| Calcinosis | 1 | 2013 | 1482 | 0.220 |
Why?
|
| Acute Coronary Syndrome | 1 | 2015 | 2194 | 0.210 |
Why?
|
| Gadolinium | 3 | 2020 | 964 | 0.200 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2496 | 0.200 |
Why?
|
| Maryland | 2 | 2019 | 278 | 0.190 |
Why?
|
| Aortic Valve Stenosis | 1 | 2013 | 2032 | 0.170 |
Why?
|
| Recurrence | 7 | 2019 | 8509 | 0.150 |
Why?
|
| Echocardiography | 3 | 2018 | 5047 | 0.150 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15949 | 0.140 |
Why?
|
| Equipment Safety | 1 | 2017 | 250 | 0.140 |
Why?
|
| Middle Aged | 21 | 2021 | 223487 | 0.130 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2017 | 511 | 0.130 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 39354 | 0.130 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2016 | 144 | 0.130 |
Why?
|
| Male | 22 | 2021 | 364731 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 4064 | 0.110 |
Why?
|
| ROC Curve | 3 | 2018 | 3628 | 0.110 |
Why?
|
| Anticoagulants | 2 | 2021 | 4850 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2020 | 3782 | 0.100 |
Why?
|
| Warfarin | 1 | 2021 | 1493 | 0.100 |
Why?
|
| Ischemic Attack, Transient | 1 | 2018 | 877 | 0.100 |
Why?
|
| Female | 21 | 2021 | 397187 | 0.100 |
Why?
|
| Pacemaker, Artificial | 1 | 2017 | 828 | 0.100 |
Why?
|
| Leukocyte Count | 1 | 2015 | 1609 | 0.100 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2016 | 775 | 0.090 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 414 | 0.090 |
Why?
|
| Electrocardiography | 3 | 2019 | 6412 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 1096 | 0.090 |
Why?
|
| Cryosurgery | 1 | 2015 | 479 | 0.090 |
Why?
|
| Organ Size | 1 | 2015 | 2267 | 0.090 |
Why?
|
| Stroke Volume | 2 | 2015 | 5622 | 0.090 |
Why?
|
| Action Potentials | 1 | 2017 | 1838 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 14729 | 0.080 |
Why?
|
| Injury Severity Score | 1 | 2013 | 1049 | 0.080 |
Why?
|
| Medication Adherence | 1 | 2021 | 2187 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2357 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 1429 | 0.080 |
Why?
|
| Aged | 13 | 2021 | 171502 | 0.080 |
Why?
|
| Cicatrix | 1 | 2014 | 798 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 2017 | 2191 | 0.080 |
Why?
|
| Laser Therapy | 1 | 2015 | 1107 | 0.080 |
Why?
|
| Humans | 23 | 2021 | 768171 | 0.080 |
Why?
|
| Treatment Outcome | 7 | 2019 | 65379 | 0.080 |
Why?
|
| Accidents, Traffic | 1 | 2013 | 818 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 2227 | 0.070 |
Why?
|
| Proportional Hazards Models | 3 | 2016 | 12543 | 0.070 |
Why?
|
| Reference Values | 1 | 2013 | 4939 | 0.060 |
Why?
|
| Stroke | 2 | 2018 | 9755 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 3941 | 0.060 |
Why?
|
| Coronary Angiography | 1 | 2015 | 4541 | 0.060 |
Why?
|
| Prospective Studies | 6 | 2018 | 54924 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2019 | 81760 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 1947 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 21538 | 0.050 |
Why?
|
| Exercise | 1 | 2017 | 5954 | 0.040 |
Why?
|
| Prognosis | 3 | 2018 | 30009 | 0.040 |
Why?
|
| Survival Rate | 1 | 2015 | 12840 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 15453 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2015 | 3433 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2021 | 382 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 13013 | 0.040 |
Why?
|
| Time Factors | 5 | 2018 | 40220 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22290 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6568 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2013 | 9384 | 0.040 |
Why?
|
| Electric Power Supplies | 1 | 2017 | 96 | 0.040 |
Why?
|
| Risk Factors | 3 | 2019 | 74944 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 36741 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20762 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18415 | 0.030 |
Why?
|
| Turkey | 1 | 2016 | 256 | 0.030 |
Why?
|
| Body Surface Potential Mapping | 1 | 2017 | 228 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2017 | 585 | 0.030 |
Why?
|
| Contrast Media | 2 | 2020 | 5330 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2016 | 317 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2018 | 898 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12077 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 4861 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15833 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 823 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2018 | 24318 | 0.020 |
Why?
|
| Heart Failure | 1 | 2015 | 11879 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2016 | 1599 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3436 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2018 | 6229 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 20225 | 0.020 |
Why?
|
| Acute Disease | 1 | 2017 | 7243 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10099 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6525 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 2735 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2014 | 2880 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 223646 | 0.010 |
Why?
|
| Patient Selection | 1 | 2016 | 4260 | 0.010 |
Why?
|
| Comorbidity | 1 | 2018 | 10590 | 0.010 |
Why?
|
| Thrombosis | 1 | 2016 | 2957 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 8080 | 0.010 |
Why?
|
| Myocardium | 1 | 2014 | 4790 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8375 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 26379 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 41753 | 0.010 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_